Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-08-07 Purchase |
2023-08-09 4:10 pm |
Vistagen Therapeutics Inc. | VTGN | COMMODORE CAPITAL LP 10% Owner |
775,756 | $23.15 | $17,961,079 | 1,575,000 (Indirect) |
View |
| 2022-08-18 Purchase |
2022-08-22 5:12 pm |
VistaGen Therapeutics Inc. | VTGN | GIN JERRY B Director |
200,000 | $0.1787 | $35,740 | 400,000 (Indirect Direct) |
View |
| 2022-08-17 Purchase |
2022-08-19 3:45 pm |
VistaGen Therapeutics Inc. | VTGN | Adler Reid G. CHIEF LEGAL OFFICER |
300,000 | $0.1697 | $50,910 | 334,629 (Direct) |
View |
| 2022-08-17 Purchase |
2022-08-18 3:56 pm |
VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
600,000 | $0.172 | $103,200 | 780,232 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-12-31 Option Award |
2025-01-13 5:40 pm |
N/A N/A |
Vistagen Therapeutics Inc. | VTGN | Prince Joshua S. Chief Operating Officer |
3,310 | $2.5075 | 5,981 (Direct) |
View |
| 2024-12-31 Option Award |
2025-01-13 5:39 pm |
N/A N/A |
Vistagen Therapeutics Inc. | VTGN | Anderson Cynthia Lynn CHIEF FINANCIAL OFFICER |
2,592 | $2.5075 | 6,184 (Direct) |
View |
| 2024-09-06 Option Award |
2024-09-10 5:00 pm |
N/A 2034-09-06 |
Vistagen Therapeutics Inc. | VTGN | SAXE JON S Director |
14,100 | $0 | 14,100 (Direct) |
View |
| 2024-09-06 Option Award |
2024-09-10 5:00 pm |
N/A 2034-09-06 |
Vistagen Therapeutics Inc. | VTGN | GIN JERRY B Director |
14,100 | $0 | 14,100 (Direct) |
View |
| 2024-09-06 Option Award |
2024-09-10 5:00 pm |
N/A 2034-09-06 |
Vistagen Therapeutics Inc. | VTGN | Curley Joanne Director |
14,100 | $0 | 14,100 (Direct) |
View |
| 2024-09-06 Option Award |
2024-09-10 5:00 pm |
N/A 2034-09-06 |
Vistagen Therapeutics Inc. | VTGN | Cunningham Ann Michelle Director |
14,100 | $0 | 14,100 (Direct) |
View |
| 2024-09-06 Option Award |
2024-09-10 5:00 pm |
N/A 2034-09-06 |
Vistagen Therapeutics Inc. | VTGN | Rotunno Mary L. Director |
14,100 | $0 | 14,100 (Direct) |
View |
| 2024-09-06 Option Award |
2024-09-10 5:00 pm |
N/A 2034-09-06 |
Vistagen Therapeutics Inc. | VTGN | FitzPatrick Margaret M Director |
14,100 | $0 | 14,100 (Direct) |
View |
| 2024-06-28 Option Award |
2024-07-02 6:10 pm |
N/A N/A |
Vistagen Therapeutics Inc. | VTGN | Prince Joshua S. Chief Operating Officer |
2,671 | $2.958 | 2,671 (Direct) |
View |
| 2024-06-28 Option Award |
2024-07-02 6:08 pm |
N/A N/A |
Vistagen Therapeutics Inc. | VTGN | Anderson Cynthia Lynn CHIEF FINANCIAL OFFICER |
3,592 | $2.958 | 3,592 (Direct) |
View |
| 2024-06-28 Option Award |
2024-07-02 6:07 pm |
N/A N/A |
Vistagen Therapeutics Inc. | VTGN | Adler Reid G. CHF CORP DEVEL OFF, GEN COUNS |
4,854 | $2.958 | 16,509 (Direct) |
View |
| 2024-06-28 Option Award |
2024-07-02 6:06 pm |
N/A N/A |
Vistagen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
4,854 | $2.958 | 31,362 (Direct) |
View |
| 2024-06-24 Option Award |
2024-06-26 9:31 pm |
N/A 2034-06-24 |
Vistagen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
500,000 | $0 | 500,000 (Direct) |
View |
| 2024-06-24 Option Award |
2024-06-26 9:30 pm |
N/A 2034-06-24 |
Vistagen Therapeutics Inc. | VTGN | Adler Reid G. CHF CORP DEVEL OFF, GEN COUNS |
170,000 | $0 | 170,000 (Direct) |
View |
| 2024-06-24 Option Award |
2024-06-26 9:30 pm |
N/A 2034-06-24 |
Vistagen Therapeutics Inc. | VTGN | Anderson Cynthia Lynn CHIEF FINANCIAL OFFICER |
150,000 | $0 | 150,000 (Direct) |
View |
| 2024-06-24 Option Award |
2024-06-26 9:29 pm |
N/A 2034-06-24 |
Vistagen Therapeutics Inc. | VTGN | Prince Joshua S. Chief Operating Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2024-03-04 Option Award |
2024-03-06 6:00 pm |
N/A 2034-03-04 |
Vistagen Therapeutics Inc. | VTGN | Rotunno Mary L. Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2024-03-04 Option Award |
2024-03-06 6:00 pm |
N/A 2034-03-04 |
Vistagen Therapeutics Inc. | VTGN | GIN JERRY B Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2024-03-04 Option Award |
2024-03-06 6:00 pm |
N/A 2034-03-04 |
Vistagen Therapeutics Inc. | VTGN | FitzPatrick Margaret M Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2024-03-04 Option Award |
2024-03-06 6:00 pm |
N/A 2034-03-04 |
Vistagen Therapeutics Inc. | VTGN | Curley Joanne Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2024-03-04 Option Award |
2024-03-06 6:00 pm |
N/A 2034-03-04 |
Vistagen Therapeutics Inc. | VTGN | Cunningham Ann Michelle Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2024-03-04 Option Award |
2024-03-06 6:00 pm |
N/A 2034-03-04 |
Vistagen Therapeutics Inc. | VTGN | SAXE JON S Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2023-12-29 Option Award |
2024-01-03 5:19 pm |
N/A N/A |
Vistagen Therapeutics Inc. | VTGN | Adler Reid G. CHF CORP DEVEL OFF, GEN COUNS |
167 | $1.717 | 11,655 (Direct) |
View |
| 2023-12-29 Option Award |
2024-01-03 5:17 pm |
N/A N/A |
Vistagen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
167 | $1.717 | 26,508 (Direct) |
View |
Ownership |
2023-11-03 8:14 pm |
N/A 2031-11-15 |
Vistagen Therapeutics Inc. | VTGN | Prince Joshua S. Chief Operating Officer |
0 | $0 | 13,335 (Direct) |
View |
| 2023-10-04 Option Award |
2023-10-06 4:05 pm |
2023-10-04 N/A |
Vistagen Therapeutics Inc. | VTGN | COMMODORE CAPITAL LP 10% Owner |
5,872,944 | $0 | 5,872,944 (Indirect) |
View |
| 2023-08-21 Option Award |
2023-08-23 1:09 pm |
N/A 2033-08-21 |
Vistagen Therapeutics Inc. | VTGN | Anderson Cynthia Lynn CHIEF FINANCIAL OFFICER |
8,333 | $0 | 8,333 (Direct) |
View |
Ownership |
2023-08-09 4:05 pm |
N/A N/A |
Vistagen Therapeutics Inc. | VTGN | COMMODORE CAPITAL LP 10% Owner |
0 | $0 | 799,244 (Indirect) |
View |
| 2023-06-30 Option Award |
2023-07-05 4:05 pm |
N/A N/A |
Vistagen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
167 | $1.5895 | 26,341 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 4:05 pm |
N/A N/A |
Vistagen Therapeutics Inc. | VTGN | Adler Reid G. CHIEF LEGAL OFFICER |
167 | $1.5895 | 11,488 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 4:05 pm |
N/A N/A |
Vistagen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE VP, CFO |
167 | $1.5895 | 3,671 (Direct) |
View |
| 2022-12-30 Option Award |
2023-01-03 4:11 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE VP, CFO AND SECRETARY |
5,000 | $0.0876 | 105,111 (Direct) |
View |
| 2022-12-30 Option Award |
2023-01-03 4:10 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
5,000 | $0.0876 | 785,232 (Direct) |
View |
| 2022-07-30 Option Award |
2022-07-15 4:30 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE VP, CFO AND SECRETARY |
5,000 | $0.748 | 100,111 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-15 4:30 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
5,000 | $0.748 | 180,232 (Direct) |
View |